arrow
返回

Osteocalcin levels decrease during the treatment of an acute depressive episode

delete2022-08-02
delete4
delete
OA
AI
E
Elis Bartečků
J
Jana Hořínková *
P
Pavel Křenek
A
Alena Damborská
J
Josef Tomandl
M
Marie Tomandlová
J
Jan Kučera
J
Jana Kučerová
J
Julie Bienertová Vašků
DOI:10.3389/fpsyt.2022.893012delete
delete原文链接
delete分享
delete收藏
查看原文
摘要

摘要

En 中文
ObjectivesOsteocalcin is a protein secreted by osteoblasts with a versatile endocrine role. Several domains in which it plays a role-stress response, monoamine synthesis, and cognitive functioning-are implicated also in the pathophysiology of major depressive disorder. In search of possible objective biomarkers of depression, the aim of the study was to assess the relationship between osteocalcin and depressive symptoms during the treatment of depressive episode. MethodsThe study included female inpatients with at least moderate depressive episode. In these patients, depression severity was measured using the Montgomery-angstrom sberg Depression Rating Scale (MADRS), and osteocalcin levels were assessed before the stabilization of antidepressive treatment and after 6 weeks. Relationships between osteocalcin levels and symptoms were analyzed with mixed-effect and linear models, taking into account age, menopausal status, and body mass index. ResultsIn 11 out of 13 enrolled inpatients, osteocalcin levels decreased during the first 6 weeks of treatment; this decrease was significant according to the mixed-effects model (t = -2.345, p = 0.019). According to the linear model, this decrease was significantly associated with reduction in depressive symptom severity (t = 2.673, p = 0.028). Osteocalcin was not associated with initial depressive symptom severity, and initial osteocalcin levels did not predict response to treatment. Limitations of the study include low sample size and inclusion of both pre- and postmenopausal women of various ages. ConclusionsThis preliminary study suggests that osteocalcin may be a candidate biomarker of antidepressive treatment response and that this topic warrants further investigation.
Keyword:
osteocalcin
major depressive disorder
biomarker
depression
antidepressant treatment
AI总结

AI总结

对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。

期刊

Frontiers in Psychiatry 封面图
Frontiers in Psychiatry
IF:
3.2
论文数:
1.8W
被引数:
4.8W

机构

U
University Hospital Brno
学者数:
1.9K
论文数: 1.2K
被引数: 2.2K
M
masaryk university brno
学者数:
1.1W
论文数: 7.8K
被引数: 9
引用论文

引用论文

Pediatric de novo movement disorders and ataxia in the context of SARS-CoV-2
err2023-07-29
err0
errOAAI
errNina-Maria Wilpert; Ana Luísa de Almeida Marcelino; Ellen Knierim; Pasquale Incoronato; Elisa Sanchez-Sendin; Olga Staudacher; Anne Drenckhahn; Petra Bittigau; Jakob Kreye; Harald Prüss; Markus Schuelke; Andrea A. Kühn; Angela M. Kaindl; Marc Nikolaus
err分享
err收藏
A POWER PRIMER电源底漆
err1992-01-01
err3.9W
PREAI
errCOHEN, J
err分享
err收藏
Relationship between long-term use of a typical antipsychotic medication by Chinese schizophrenia patients and the bone turnover markers serum osteocalcin and β-CrossLaps
err2016-10-01
err23
PREAI
errZhang, Beibei; Deng, Lu; Wu, Haishan; Lu, Xiaozi; Peng, Lihong; Wu, Renrong; Guo, Wenbin; Chen, Jindong; Li, Lehua; Zhao, Jingping
err分享
err收藏
err分享
err收藏
Bone mineral density in women with depression
err1996-10-17
err391
errOAAI
errMichelson, D; Stratakis, C; Hill, L; Reynolds, J; Galliven, E; Chrousos, G; Gold, P
err分享
err收藏
Cortisol and Major Depressive Disorder-Translating Findings From Humans to Animal Models and Back
err2020-01-22
err165
errOAAI
errNandam, L. Sanjay; Brazel, Matthew; Zhou, Mei; Jhaveri, Dhanisha J.
err分享
err收藏
学者 查看更多内容